These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 1849076

  • 1. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.
    Delcayre AX, Salas F, Mathur S, Kovats K, Lotz M, Lernhardt W.
    EMBO J; 1991 Apr; 10(4):919-26. PubMed ID: 1849076
    [Abstract] [Full Text] [Related]

  • 2. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.
    Carel JC, Myones BL, Frazier B, Holers VM.
    J Biol Chem; 1990 Jul 25; 265(21):12293-9. PubMed ID: 1695627
    [Abstract] [Full Text] [Related]

  • 3. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.
    Nemerow GR, Mold C, Schwend VK, Tollefson V, Cooper NR.
    J Virol; 1987 May 25; 61(5):1416-20. PubMed ID: 3033269
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies.
    Barel M, Fiandino A, Lyamani F, Frade R.
    Proc Natl Acad Sci U S A; 1989 Dec 25; 86(24):10054-8. PubMed ID: 2557614
    [Abstract] [Full Text] [Related]

  • 5. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21).
    Esparza I, Becherer JD, Alsenz J, De la Hera A, Lao Z, Tsoukas CD, Lambris JD.
    Eur J Immunol; 1991 Nov 25; 21(11):2829-38. PubMed ID: 1834472
    [Abstract] [Full Text] [Related]

  • 6. Stable expression and function of EBV/C3d receptor following genomic transfection into murine fibroblast L cells.
    Cantaloube JF, Piechaczyk M, Calender A, Lenoir G, Minty A, Carrière D, Fischer E, Poncelet P.
    Eur J Immunol; 1990 Feb 25; 20(2):409-16. PubMed ID: 1690137
    [Abstract] [Full Text] [Related]

  • 7. Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interaction.
    Molina H, Brenner C, Jacobi S, Gorka J, Carel JC, Kinoshita T, Holers VM.
    J Biol Chem; 1991 Jul 05; 266(19):12173-9. PubMed ID: 1712014
    [Abstract] [Full Text] [Related]

  • 8. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM, Fowler E, Lambris JD, Feighny RJ, Simmons JG, Ross GD.
    J Immunol; 1983 Mar 05; 130(3):1309-12. PubMed ID: 6218205
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor.
    Ahearn JM, Hayward SD, Hickey JC, Fearon DT.
    Proc Natl Acad Sci U S A; 1988 Dec 05; 85(23):9307-11. PubMed ID: 2848261
    [Abstract] [Full Text] [Related]

  • 11. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.
    Weis JJ, Toothaker LE, Smith JA, Weis JH, Fearon DT.
    J Exp Med; 1988 Mar 01; 167(3):1047-66. PubMed ID: 2832506
    [Abstract] [Full Text] [Related]

  • 12. Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21).
    Young KA, Chen XS, Holers VM, Hannan JP.
    J Biol Chem; 2007 Dec 14; 282(50):36614-25. PubMed ID: 17925391
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface.
    Guthridge JM, Young K, Gipson MG, Sarrias MR, Szakonyi G, Chen XS, Malaspina A, Donoghue E, James JA, Lambris JD, Moir SA, Perkins SJ, Holers VM.
    J Immunol; 2001 Nov 15; 167(10):5758-66. PubMed ID: 11698449
    [Abstract] [Full Text] [Related]

  • 15. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor.
    Pernegger G, Schulz TF, Hosp M, Myones BL, Petzer AL, Eigentler A, Böck G, Wick G, Dierich MP.
    Immunology; 1988 Oct 15; 65(2):237-41. PubMed ID: 2461345
    [Abstract] [Full Text] [Related]

  • 16. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
    Weis JJ, Fearon DT, Klickstein LB, Wong WW, Richards SA, de Bruyn Kops A, Smith JA, Weis JH.
    Proc Natl Acad Sci U S A; 1986 Aug 15; 83(15):5639-43. PubMed ID: 3016712
    [Abstract] [Full Text] [Related]

  • 17. Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site.
    Myones BL, Ross GD.
    Complement; 1987 Aug 15; 4(2):87-98. PubMed ID: 3497773
    [Abstract] [Full Text] [Related]

  • 18. Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines.
    Cohen JH, Fischer E, Kazatchkine MD, Lenoir GM, Lefevre-Delvincourt C, Revillard JP.
    Scand J Immunol; 1987 Jun 15; 25(6):587-98. PubMed ID: 3037684
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats.
    Moore MD, Cannon MJ, Sewall A, Finlayson M, Okimoto M, Nemerow GR.
    J Virol; 1991 Jul 15; 65(7):3559-65. PubMed ID: 1645784
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis.
    Tanner J, Weis J, Fearon D, Whang Y, Kieff E.
    Cell; 1987 Jul 17; 50(2):203-13. PubMed ID: 3036369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.